logo

For the Inventor, By the Inventor

Nanjing, China

Biosion, Inc.


USPTO Granted Patents = 11


Trademarks = 1

Forward Citations = 0

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Mingjiu Chen (10 out of 10 patents)

silverMedal Shukai Xia (7 out of 7 patents)

bronzeMedal Mark Zhiqing MA (4 out of 4 patents)

4.  Hongjiang Xu (3 out of 31 patents)

5.  Zhengping Zhang (3 out of 3 patents)

6.  Cathy Xiaoyan Zhong (3 out of 3 patents)

7.  Wei Tan (2 out of 2 patents)

8.  Jinyu Liu (1 out of 1 patent)

9.  Zeyu Peng (1 out of 1 patent)

10.  Xiaofang Zou (1 out of 2 patents)

11.  Zhijian Lu (1 out of 1 patent)

12.  Wei Song (1 out of 1 patent)


11 patents:

1. 12735495 - ANTIBODIES BINDING IL4R AND USES THEREOF (2026-09-15),
2. 12723082 - MONOCLONAL ANTIBODIES WHICH BIND PD-1, ENCODING NUCLEOTIDES THEREOF AND METHOD OF USE THEREOF TO TREAT CANCER, INFECTIOUS DISEASE AND INFLAMMATORY DISEASE (2026-09-01),
3. 12715931 - NANOBODIES BINDING TROP2 AND USES THEREOF (2026-08-25),
4. 12703763 - ANTIBODIES BINDING C5 AND USES THEREOF (2026-08-11),
5. 12679900 - ANTIBODIES BINDING RANKL AND USES THEREOF (2026-07-14),
6. 12649789 - ANTIBODIES BINDING SIGLEC15 AND USES THEREOF (2026-06-09),
7. 12559565 - ANTIBODIES BINDING CTLA4 AND USES THEREOF (2026-02-24),
8. 12503517 - ANTIBODIES BINDING CD40 AND USES THEREOF (2025-12-23),
9. 12479912 - MONOCLONAL ANTIBODIES WHICH BIND THYMIC STROMAL LYMPHOPOIETIN (TSLP), ENCODING POLYNUCLEOTIDES THEREOF AND METHODS OF USE THEREOF TO TREAT DISEASES (2025-11-25),
10. 11739147 - Antibodies binding Siglec15 and uses thereof (2023-08-29),
11. 11390685 - ErbB2 antibodies and uses therefore (2022-07-19),
Company Overview
Biosion, Inc. is a biotechnology company based in Nanjing, China, specializing in the development of innovative therapeutic solutions. The organization focuses on biologics and antibody-drug conjugates, leveraging advanced technologies to enhance drug discovery and development processes. With a commitment to improving healthcare outcomes, Biosion integrates cutting-edge research in protein engineering and pharmacology, aiming to address unmet medical needs through its proprietary platforms and collaborative partnerships.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

11 Patents

#40 in Nanjing

#2,552 in China

#51,761 in the World

Nanjing, CN
Nanjing, China

Biosion, Inc.

Forward Citations = 0

12 inventors:

goldMedal Mingjiu Chen (10 out of 10 patents)

silverMedal Shukai Xia (7 out of 7 patents)

bronzeMedal Mark Zhiqing MA (4 out of 4 patents)

4.  Hongjiang Xu (3 out of 31 patents)

5.  Zhengping Zhang (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biosion, Inc.. Retrieved from https://idiyas.com/company/biosion

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…